Grupo de Virología Evolutiva
VIREVO
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (4)
2022
-
Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain
Microorganisms, Vol. 10, Núm. 4
2019
-
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671
2016
2013
-
Immune Activation Promotes Evolutionary Conservation of T-Cell Epitopes in HIV-1
PLoS Biology, Vol. 11, Núm. 4